0503.HK
Lansen Pharmaceutical Holdings Limited [0503.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0503.HK Stock Summary
In the News
0503.HK Financial details
Company Rating
-
Market Cap
750.6M
Income
7.41M
Revenue
64.95M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
652
Optionable
No
Shortable
Yes
Earnings
24 Aug 2023
P/E
11.2
Forward P/E
-
PEG
0.16
P/S
1.46
P/B
0.79
P/C
-
P/FCF
5.79
Quick Ratio
0.86
Current Ratio
2.21
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.02
EPS next Y
-
EPS next Q
-
EPS this Y
831.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
119.76%
Revenue last 5Y
2.88%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
5%
ROE
7%
ROC
0.11%
Gross Margin
68%
Oper. Margin
22%
Profit Margin
13%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.2-1.815439
52W High
-
52W Low
-
RSI
-
Rel Volume
29.29
Avg Volume
476.56K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.917
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 476.56K
- Market Capitalization 750.6M
- Employee 652
- CEO Mr. Li Chen
- Headquarters Ningbo,CN
- IPO Date 2010-05-07
-
Website
https://www.lansen.com.cn 
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
